Impact of Advertising on Prescription Drugs
WASHINGTON - According to a study by the National Institute for Health Care Management (NIHCM) Research and Educational Foundation, prescription drugs that are heavily advertised to consumers are responsible for a significant portion of the recent rise in pharmaceutical spending in the US. 25 top selling medicines promoted to consumers in 1999 accounted for 40.7% -- or $7.2 billion -- increase in retail drug spending.
The anti-allergy drug Claritin topped the list of drugs promoted most widely to consumers for the second year in a row. Schering-Plough spent $137 million advertising various forms of Claritin to consumers in 1999. The study found that sales of Claitin were up 21% from 1998 to 1999. Other leading drugs were Zytec (Pfizer), Allegra (Aventis), and Celebrex had the most successful prescription drug launch in history, reaching sales of almost $1.3 billion in its first year.
A spokesperson for NIHCM says these numbers should raise many questions. Among the most important is whether pharmaceutical companies are more focused on becoming marketing powerhouses or developing truly innovative new drugs. Proponents argue that the ads have added to the information consumers are receiving about health conditions and diseases. For more information visit www.nihcm.org,
Together We Rise: Why AORN Expo 2025 Is a Must for Every Perioperative Nurse
March 31st 2025From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
